3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Kidney Neoplasms
1
Glioma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
Radiosurgery
10
Temozolomide
8
pembrolizumab
6
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nivolumab
4
Bevacizumab
4
Receptors, Interleukin-8B
3
Memantine
3
trastuzumab deruxtecan
2
abemaciclib
2
Watchful Waiting
2
Surveys and Questionnaires
2
Radiotherapy
2
Radiation
2
Mental Status and Dementia Tests
2
Ipilimumab
2
Biopsy
2
vorasidenib
1
sotorasib
1
sapanisertib
1
sacituzumab govitecan
1
ribociclib
1
pertuzumab
1
osimertinib
1
lenvatinib
1
fluciclovine F-18
1
entrectinib
1
encorafenib
1
elacestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Blood Component Removal
×
30 days
×
Clear all
No trials found.